

Neuron-specific enolase (NSE) is a protein enzyme involved in energy metabolism, normally found in nerve cells and neuroendocrine tissues. Under normal conditions, only very small amounts of NSE circulate in the blood. Elevated levels, however, can indicate nerve cell damage or abnormal growth of neuroendocrine tumors.
The NSE (Neuron Specific Enolase), Serum test measures the level of NSE in the blood and is primarily used as a tumor marker for small cell lung cancer and neuroblastoma, a type of cancer that arises in immature nerve cells and predominantly affects infants and children. Doctors may also advise this test to monitor treatment response or to check for cancer recurrence. In addition to its role in cancer detection, the NSE test may be performed alongside other diagnostic tests to evaluate other neuroendocrine tumors, certain brain disorders, or severe bodily injury or trauma, as damaged neurons and neuroendocrine cells release NSE into the blood.
It is important to note that while high NSE levels may indicate one of these cancers, brain injuries, or neuroendocrine conditions, the test alone cannot confirm a diagnosis, and further tests are needed for confirmation.
No special preparation is needed for getting the NSE (Neuron Specific Enolase), Serum test done. However, be sure to inform the doctor about any medications or supplements being taken, as they may affect the test results.
Lab test results may vary across different laboratories. Abnormal test results require expert interpretation. Therefore, never try to self-medicate based solely on these results. Always consult a doctor for a proper understanding of the test results.
Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The NSE (Neuron Specific Enolase), Serum test measures the level of neuron-specific enolase (NSE) in the blood, an enzyme primarily found in nerve cells and neuroendocrine tissues that plays a key role in energy metabolism. When these cells are damaged, injured, or grow abnormally, as in cancers such as small cell lung cancer, neuroblastoma, medullary thyroid carcinoma, or carcinoid tumors, they release excess NSE into the blood. Elevated NSE levels may also occur in brain injury, stroke, or other neurological conditions. Normal or low NSE levels are generally not a cause for concern, but must still be interpreted alongside clinical findings and other diagnostic tests. NSE is not entirely specific; it may rise in some non-cancerous conditions as well, so doctors typically use this test in combination with imaging studies and other tumor markers to arrive at an accurate diagnosis.
The NSE (Neuron Specific Enolase), Serum test is done:
- To help diagnose and monitor small cell lung cancer and neuroblastoma
- To check for the presence or recurrence of neuroendocrine tumors
- To evaluate the effectiveness of cancer treatment
- To assess brain injury, stroke, or neurological damage
- To help differentiate between cancer types in certain clinical cases
- No special preparation is required.

































